Stephen Scelsa, MD

I am a  neurologist and  neuromuscular specialist with expertise in Amyotrophic Lateral Sclerosis (ALS) clinical care and trials.  I am the co-founder and Director of the Beth Israel Medical Center/ALS Association NY Chapter ALS Center that  was created in 1997.  Since 2003, the center has gained national recognition for participation in ALS clinical trials. I have access to a large population of patients with Amyotrophic Lateral Sclerosis. We became part of the Mount Sinai Health System in 2013. We follow 120 patients at any given time. I am an active member of NEALS, the Northeastern ALS Consortium. I have a strong interest in conducting clinical trials in ALS and other neuromuscular diseases.

At Mount Sinai Beth Israel, we conducted an investigator initiated phase1/2 trial of indinavir in ALS, in collaboration with Columbia University Medical Center. I was the principal investigator.

Our center has also conducted a controlled study of reverse transcriptase detection in the serum and CSF of HIV negative, sporadic ALS patients.  We have been involved in multiple clinical trials sponsored by industry and NIH.  Our primary research interest is in drug development in ALS.

We are also participating in a new study to validate a new functional scale for PLS (primary lateral sclerosis) with Dr Mitsumoto at Columbia University. PLS is a neglected disease in clinical trials.  I am very interested in developing new clinical trials in PLS and this project provides a great opportunity.

I offer telemedicine appointments when appropriate.  Please call my office to schedule a video visit.

Dr. Scelsa is registered to provide telehealth services in New Jersey.

Curriculum Vitae

The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.